Letters BCG vaccination and TB in children

Contraindicated BCG vaccination in “at risk” infants

BMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g5388 (Published 10 September 2014) Cite this as: BMJ 2014;349:g5388
  1. Philippa Rees, intercalated MPhil medical student1,
  2. Huw Evans, academic foundation year 2 doctor1,
  3. Sukhmeet Panesar, honorary fellow2,
  4. Meirion Llewelyn, consultant in infectious diseases3,
  5. Adrian Edwards, professor of general practice and institute director1,
  6. Andrew Carson-Stevens, clinical lecturer in healthcare improvement1
  1. 1Cochrane Institute of Primary Care and Public Health, School of Medicine, Cardiff University, Cardiff CF14 4YS, UK
  2. 2Centre for Population and Health Sciences, University of Edinburgh, Edinburgh, UK
  3. 3Royal Gwent Hospital, Newport, UK
  1. carson-stevensap{at}cardiff.ac.uk

Roy and colleagues highlight the effectiveness of the BCG vaccine in preventing tuberculosis in immunocompetent children.1 However, those responsible for prescribing and administering BCG vaccinations must be mindful of the contraindications for immunocompromised children.2

Our study of primary care related paediatric safety incidents from the England and Wales National Reporting and Learning System identified 1790 vaccine related incidents during 2005-13.3 Despite under-reporting of safety incidents, we found 99 reports of …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe